Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Keuzehulp ondersteunt samen beslissen en therapietrouw
apr 2019 | Multipele Sclerose